Skip to main content
. Author manuscript; available in PMC: 2020 Apr 1.
Published in final edited form as: Invest New Drugs. 2018 Jun 22;37(2):238–251. doi: 10.1007/s10637-018-0622-9

Table 1.

Pharmacokinetics of resveratrol (RVT) and benzo(a)pyrene (BaP; alone and in the presence of RVT) orally administered to ApcMin/+ male mice.

Parameter RVT BaP BaP + RVT
Area under curve (AUC; mg x h/ml) 0.10 ± 0.01 0.12 ± 0.005 0.07 ± 0.005
Biological half-life (t1/2; hrs) 1.0 ± 0.011 1.8 ± 0.018 0.85 ± 0.010*
Volume of distribution (Vd; ml/kg) 0.44 ± 0.050 0.58 ± 0.045 0.22 ± 0.064
Clearance (Cl; ml/hr/kg) 0.08 ± 0.006 0.10 ± 0.01 0.05 ± 0.004*
Mean residence time (MRT; hrs) 1.6 ± 0.018 2.4 ± 0.010 1.2± 0.004*
Elimination rate (Kd; hrs) 0.18 ± 0.03 0.17 ± 0.06 0.23 ± 0.004

Values represent mean ± standard error (n = 10). Asterisks denote statistical significance (p < 0.05) of toxicokinetic parameter values for BaP and RVT administered together compared to BaP alone administration.